Vishwamintra Persaud Md New York City, NY - 10003

Vishwamintra Persaud Md is categorized under Internal Medicine Practitioners in New York City, NY and active since 2003.

Vishwamintra Persaud Md was established in 2003, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Vishwamintra Persaud at the company’s single location by writing to 308a East 15th St, New York City, New York NY 10003 or by phoning (212) 420-6460. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Vishwamintra Persaud Md
Contact Person: Vishwamintra Persaud
Address: 308a East 15th St, New York City, New York 10003
Phone Number: (212) 420-6460
Annual Revenue (USD): $50.000 to $99.999
Founded: 2003
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Vishwamintra Persaud Md was started in 2003 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Vishwamintra Persaud for inquiries that concern Vishwamintra Persaud Md by calling the company number (212) 420-6460, as your correspondence is most welcome. Additionally, the physical location of the single location of Vishwamintra Persaud Md can be found at the coordinates 40.73266,-73.983917 as well as the street address 308a East 15th St in New York City, New York 10003.

For its online presence, you may visit Vishwamintra Persaud Md’s website at and engage with its social media outlets through on Twitter and on Facebook.